| dc.contributor.author |
Nurlegn, Serkalem |
|
| dc.date.accessioned |
2025-03-26T08:27:16Z |
|
| dc.date.available |
2025-03-26T08:27:16Z |
|
| dc.date.issued |
44531 |
|
| dc.identifier.citation |
Submitted by iphce iphce (iphce-e@gmail.com) on 2025-03-26T08:27:16Z
No. of bitstreams: 0 |
en_US |
| dc.identifier.citation |
Made available in DSpace on 2025-03-26T08:27:16Z (GMT). No. of bitstreams: 0
Previous issue date: 2021-12 |
en_US |
| dc.description.abstract |
Earlier reports of high prevalence of thrombosis and related mortality has led to use of
anticoagulants being part of the main treatment with varying results. Despite current
large scale data showing credible benefits there are no studies done to determine the
pattern of anticoagulation use and outcome in COVID patients in Ethiopia. |
en_US |
| dc.language.iso |
https://etd.aau.edu.et/items/d2f1cb0c-4791-47a0-b163-9a8919da1474 |
|
| dc.language.iso |
en_US |
en_US |
| dc.subject |
Infectious diseases/COVID 19 |
|
| dc.title.alternative |
Patterns of Anticoaulation and Outcome in COVID -19 Patients admitted to TASH Isolation Center, Addis Ababa, Ethiopia: Retrospective Study (June 2020-June 2021) |
en_US |
| dc.type |
Thesis |
S |